MAM
ABBV icon

McLean Asset Management’s AbbVie ABBV Stock Holding History

McLean Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$697K Buy
3,204
+100
+3% +$22.2K 0.12% 77
2025
Q4 		$689K Sell
3,104
-191
-6% -$43.5K 0.12% 77
2025
Q3 		$759K Buy
3,295
+12
+0.4% +$2.44K 0.16% 73
2025
Q2 		$626K Buy
3,283
+130
+4% +$24.2K 0.16% 71
2025
Q1 		$554K Sell
3,153
-37
-1% -$7.19K 0.18% 69
2024
Q4 		$567K Sell
3,190
-233
-7% -$42.8K 0.17% 71
2024
Q3 		$665K Buy
3,423
+509
+17% +$95K 0.2% 67
2024
Q2 		$490K Buy
2,914
+93
+3% +$15.4K 0.16% 76
2024
Q1 		$480K Buy
2,821
+24
+0.9% +$4.14K 0.16% 75
2023
Q4 		$454K Sell
2,797
-157
-5% -$22.9K 0.17% 70
2023
Q3 		$440K Buy
2,954
+210
+8% +$30.8K 0.18% 65
2023
Q2 		$370K Sell
2,744
-167
-6% -$24.5K 0.15% 84
2023
Q1 		$464K Sell
2,911
-415
-12% -$63.4K 0.19% 62
2022
Q4 		$538K Buy
3,326
+259
+8% +$39.7K 0.18% 61
2022
Q3 		$426K Sell
3,067
-64
-2% -$9.18K 0.16% 62
2022
Q2 		$478K Buy
3,131
+105
+3% +$16K 0.19% 59
2022
Q1 		$491K Sell
3,026
-97
-3% -$14.1K 0.36% 53
2021
Q4 		$429K Sell
3,123
-445
-12% -$52.6K 0.17% 66
2021
Q3 		$391K Buy
3,568
+1,141
+47% +$130K 0.15% 75
2021
Q2 		$285K Buy
2,427
+136
+6% +$15.3K 0.13% 80
2021
Q1 		$255K Buy
2,291
+85
+4% +$9.09K 0.2% 82
2020
Q4 		$236K Buy
+2,206
New +$212K 0.21% 77

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

McLean Asset Management's ABBV Position: Q1 2026 in Review

McLean Asset Management increased its AbbVie (ABBV) stake by 3.2% in Q1 2026, buying an estimated $22.2K and bringing the position to 3,204 shares worth $697K. The position accounts for 0.12% of the portfolio, ranked #77.

McLean Asset Management first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $759K in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • McLean Asset Management held 3,204 shares of AbbVie worth $697K as of Q1 2026.
  • McLean Asset Management bought 100 AbbVie shares in Q1 2026, an estimated $22.2K.
  • AbbVie made up 0.12% of McLean Asset Management's portfolio in Q1 2026, its #77 holding.
  • McLean Asset Management first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • McLean Asset Management's AbbVie position peaked at $759K in Q3 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on McLean Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.